+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

IL22

Catalog No Product Description CAS No. Purity Structural Formula
BP2082
Hamaudol
Hamaudol has analgesic and anti-inflammary activities, it showed inhibitory activity on COX-1 and COX-2 activities with values of 0.30, 0.57 mM, respectively.
735-46-6 98% Hamaudol
BP2200 903559-03-5 98% Kissoone C
BP4291
Physalin F
Physalin F is a physalin with antimalarial and antitumour activities isolated from Physalis angulata. It has a role as an antineoplastic agent, an immunosuppressive agent, an antimalarial, an apoptosis inducer and an antileishmanial agent. It is an epoxy steroid, a lactone, an enone and a physalin.
57423-71-9 98% Physalin F
BP1870
Ivangustin
Ivangustin exhibits remarkable cytotoxicity against HEp2, SGC-7901 and HCT116 human cancer cell lines.
14164-59-1 98% Ivangustin
BP2243 37415-57-9 98% 4-Deoxy-4α-phorbol
BP3181
Heraclenin
Heraclenin has anticoagulant, and anti-inflammatory activities, it also has mutagenicity in Chlamydomonas reinhardii. Heraclenin can induce apoptosis in Jurkat leukemia cells, it has a strong clastogenic effect . (+)-Heraclenin displays significant levels of antiplasmodial and moderate levels of antimicrobial activities.
2880-49-1 98% Heraclenin
BP4781
Tapinarof
Benvitimod is a stilbenoid.
79338-84-4 98% Tapinarof
BP5194
9,10-Anthracenedione,3-[[6-O-acetyl-2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-1,6-dihydroxy-2-methyl-
1,3,6-trihydroxy-2-methyl-9,10-anthraquinone-3-O-(6'-O-acetyl)-alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranoside is a disaccharide derivative that is 1,3,6-trihydroxy-2-methyl-9,10-anthraquinone attached to a (6'-O-acetyl)-alpha-L-rhamnopyranosyl-(12)-beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It has been isolated from the roots of Rubia yunnanensis. It has a role as an antineoplastic agent and a plant metabolite.
87686-87-1 98% 9,10-Anthracenedione,3-[[6-O-acetyl-2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-1,6-dihydroxy-2-methyl-
SBP00333
Braylin
Braylin has anti-inflammatory, antinociceptive and immunomodulatory effects, which possibly act through the glucocorticoid receptor activation and by inhibition of the transcriptional activity of NF-κB. Braylin is also a phosphodiesterase-4 inhibitor, it could represent an ideal prototype of glucocorticoid receptor ligand, able to induce synergic immunomodulatory effects.
6054-10-0 98% Braylin